Recent News

• 03.18.2025 - Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.25.2025 - Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
• 02.24.2025 - Maravai LifeSciences completes acquisition of the DNA and RNA business of Officinae Bio
• 02.03.2025 - TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
• 01.28.2025 - Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
• 01.28.2025 - Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
• 01.28.2025 - Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies

Recent Filings

• 03.04.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 02.25.2025 - 8-K Current report
• 02.25.2025 - EX-99.1 EX-99.1
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.31.2025 - 144 Report of proposed sale of securities
• 01.28.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.17.2025 - 4 Statement of changes in beneficial ownership of securities